✦ LIBER ✦

Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for Subacute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation

✍ Scribed by Gregory A. Yanik; Shin Mineishi; John E. Levine; Carrie L. Kitko; Eric S. White; Mark T. Vander Lugt; Andrew C. Harris; Thomas Braun; Kenneth R. Cooke

Book ID: 116282843
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 275 KB
Volume: 18
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2011.11.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Soluble tumor necrosis factor receptor:

Soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome following allogeneic stem cell transplantation

✍ G.A. Yanik; J.P. Uberti; J.L.M. Ferrara; J.E. Levine; R.J. Hutchinson; V.T. Ho; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Recombinant human soluble tumor necrosis

Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

✍ Alessandro Busca; Franco Locatelli; Filippo Marmont; Cristina Ceretto; Michele F 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

## Abstract Etanercept is a recombinant human soluble tumor necrosis factor (TNF‐α) receptor fusion protein that inhibits TNF‐α, a major mediator in the pathogenesis of graft‐versus‐host disease (GVHD). The purpose of our study was to evaluate the safety and efficacy of etanercept therapy in 21 pat